DV
Dividend Vision

DRUG — Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (DRUG)

Total return is 183.1% over the past 5.4 years, 70.8 points ahead of SPY at 112.3%. Its deepest 1-year drawdown was 38.4%.

This equity fund focuses on biosciences companies within the healthcare and life sciences sector. The fund currently does not distribute dividends to shareholders, making it oriented toward capital appreciation rather than income generation. With minimal publicly available data on expense ratios and assets under management, this fund is most suited for growth-focused investors seeking exposure to the biosciences industry rather than those prioritizing dividend income.

DRUG key facts

Asset type
Stock
Asset class
Equity
Inception date
03/22/2021
Distribution frequency
None
Last close
$76.44
Market cap
$750,033,984
Average volume
151400.0
Beta
0.091
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.40